BioForward Member Profile: Versiti

BioForward Member Profile: Versiti

BioForward is reaching out to members to highlight their organizations through a new member profile feature to tell more of their stories. Versiti agreed to be interviewed as a part of our efforts to heighten the awareness of our region. About your organization...

SHINE Submits Drug Master File

We’re excited to announce that SHINE submitted a Drug Master File with the FDA for non-carrier-added lutetium-177 (Lu-177) chloride, a radiopharmaceutical at the forefront of precision cancer treatment.  In targeted cancer therapy, the cancer-killing...